Vertebrate Antibodies Limited (VAL) was formed by research scientists from the University of Aberdeen with a wealth of experience in the development of high performance antibodies. VAL’s selection of vertebrate antibodies covers a wide spectrum of veterinary species including lower vertebrates. Their antibodies are ideal for research in human cancer and new territories such as the aquaculture industry. With multiple species of fish antibodies available, VAL provides the perfect tools for producing vaccines and diagnostics for fish health.
Vertebrate Antibodies Limited recently developed the EpitoGen COVID-19 ELISA tests, the only epitope-based ELISA tests and the only tests to utilize 5 viral COVID-19 antigens and include prevalent mutations. These tests are based on the new EpitoGen Technology that increases the sensitivity and specificity of COVID-19 tests.